Camrelizumab/LenvatinibCerebral haemorrhage and immune-related pneumonia: 2 case reports

被引：0

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2038卷 / 1期

关键词：

D O I：

10.1007/s40278-024-72179-3

中图分类号：

学科分类号：

摘要：

引用

页码：70 / 70

共 50 条

[1] Camrelizumab/catequentinibGrade 2 immune-related pneumonia: case report
Reactions Weekly, 2022, 1903 (1) : 106 - 106
[2] Immune-Related Colitis Induced by Camrelizumab: A Case Report
Cheng, Sheng
Yang, Yun
Yu, Junxian
Chen, Wei
Li, Xingang
JOURNAL OF INFLAMMATION RESEARCH, 2023, 16 : 1727 - 1731
[3] Camrelizumab-induced immune-related adverse events: Two case reports and literature review
Ge, Lingzhi
Chen, Wenfang
Zhang, Ge
Wei, Fangli
ASIAN JOURNAL OF SURGERY, 2024, 47 (06) : 2733 - 2734
[4] Fatal immune-related hepatitis with intrahepatic cholestasis and pneumonia associated with camrelizumab: A case report and literature review
Tan, Youwen
Ye, Yun
Chen, Li
OPEN MEDICINE, 2021, 16 (01): : 553 - 557
[5] Camrelizumab/Carboplatin/CisplatinNeutropenia and pneumonia: 2 case reports
Reactions Weekly, 2024, 2022 (1) : 77 - 77
[6] Bevacizumab/ipilimumab/pembrolizumabBrain haemorrhage, immune-related hypophysitis and immune-related hepatitis: case report
Reactions Weekly, 2017, 1633 (1) : 125 - 125
[7] NivolumabVarious immune-related adverse effects: 2 case reports
Reactions Weekly, 2022, 1894 (1) : 258 - 258
[8] Nivolumab/pembrolizumabCNS immune-related adverse events: 2 case reports
Reactions Weekly, 2021, 1838 (1) : 404 - 404
[9] Ipilimumab/nivolumabRheumatological immune-related adverse events: 2 case reports
Reactions Weekly, 2020, 1831 (1) : 171 - 171
[10] Ipilimumab/lenalidomidePulmonary embolism and immune-related dermatitis: 2 case reports
Reactions Weekly, 2017, 1639 (1) : 168 - 168

← 1 2 3 4 5 →